What is Lifeward's operating income?

Lifeward's total operating income in 2025 was -$19.67 million, based on the following breakdown: Total Gross Profit: $8.43 million Total Operating Expenses: $28.10 million

Lifeward (LFWD) Financials

$7.55 -0.36 (-4.55%)

Closing price 04:00 PM Eastern

Extended Trading

$7.80 +0.25 (+3.30%)

As of 07:36 PM Eastern

Compare

Annual Income Statements for Lifeward

This table shows Lifeward's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-25	-33	-25	-22	-16	-13	-13	-20	-22	-29	-20
Consolidated Net Income / (Loss)	-25	-33	-25	-22	-16	-13	-13	-20	-22	-29	-20
Net Income / (Loss) Continuing Operations	-25	-33	-25	-22	-16	-13	-13	-20	-22	-29	-20
Total Pre-Tax Income	-25	-33	-25	-22	-16	-13	-13	-19	-22	-29	-20
Total Operating Income	-25	-30	-22	-19	-14	-12	-13	-19	-24	-29	-20
Total Gross Profit	0.21	0.74	3.10	2.83	2.73	2.19	2.90	1.91	4.45	8.22	8.43
Total Revenue	3.75	5.87	7.75	6.55	4.87	4.39	5.97	5.51	14	26	22
Operating Revenue	3.75	5.87	7.75	6.55	4.87	4.39	5.97	5.51	14	26	22
Total Cost of Revenue	3.53	5.13	4.65	3.72	2.15	2.20	3.06	3.61	9.40	17	14
Operating Cost of Revenue	3.53	5.13	4.65	3.72	2.15	2.20	3.06	3.61	9.40	17	14
Total Operating Expenses	25	31	25	22	17	14	16	21	28	38	28
Selling, General & Admin Expense	6.40	8.19	7.69	6.79	5.26	4.98	5.63	7.13	10.00	5.20	8.20
Marketing Expense	13	14	11	7.90	6.17	5.75	6.99	9.84	14	18	14
Research & Development Expense	5.94	9.03	6.04	7.35	5.35	3.46	2.94	4.03	4.15	4.63	3.25
Impairment Charge	-	-	-	-	-	-	-	0.00	0.00	9.79	2.78
Total Other Income / (Expense), net	0.00	-2.06	-2.61	-2.47	-1.50	-0.92	0.00	0.00	1.47	0.45	-0.30
Other Income / (Expense), net	-	-2.06	-2.29	-2.47	-1.50	-	-	-	1.47	0.45	-0.30
Income Tax Expense	0.05	0.00	0.12	-0.01	0.01	0.05	0.09	0.47	-0.01	0.04	-0.06
Basic Earnings per Share	($2.10)	($2.47)	($30.57)	($14.72)	($2.70)	($0.82)	($0.27)	($2.20)	($31.13)	($39.96)	($17.16)
Weighted Average Basic Shares Outstanding	12.12M	13.18M	808.56K	1.47M	5.76M	15.76M	47.94M	8.91M	710.94K	724.27K	1.16M
Diluted Earnings per Share	($2.10)	($2.47)	($30.57)	($14.72)	($2.70)	($0.82)	($0.27)	($2.20)	($31.13)	($39.96)	($17.16)
Weighted Average Diluted Shares Outstanding	12.12M	13.18M	808.56K	1.47M	5.76M	15.76M	47.94M	8.91M	710.94K	724.27K	1.16M
Weighted Average Basic & Diluted Shares Outstanding	12.12M	13.18M	808.56K	1.47M	5.76M	15.76M	47.94M	59.48M	59.48M	10.63M	1.53M

This table shows Lifeward's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-7.53	-5.64	-6.28	-4.30	-3.08	-15	-4.83	-6.56	-3.17	-5.35	-11
Consolidated Net Income / (Loss)	-7.53	-5.64	-6.28	-4.30	-3.08	-15	-4.83	-6.56	-3.17	-5.35	-11
Net Income / (Loss) Continuing Operations	-7.53	-5.64	-6.28	-4.30	-3.08	-15	-4.83	-6.56	-3.17	-5.35	-11
Total Pre-Tax Income	-7.53	-5.72	-6.27	-4.30	-3.06	-15	-4.82	-6.56	-3.16	-5.42	-11
Total Operating Income	-7.94	-6.14	-6.50	-4.44	-3.17	-15	-4.85	-6.56	-3.14	-5.12	-10
Total Gross Profit	0.86	2.44	1.40	2.76	2.22	1.84	2.12	2.51	2.71	1.09	1.34
Total Revenue	4.40	6.88	5.28	6.71	6.13	7.55	5.03	5.72	6.20	5.08	3.92
Operating Revenue	4.40	6.88	5.28	6.71	6.13	7.55	5.03	5.72	6.20	5.08	3.92
Total Cost of Revenue	3.54	4.44	3.89	3.95	3.91	5.70	2.91	3.21	3.49	3.99	2.58
Operating Cost of Revenue	3.54	4.44	3.89	3.95	3.91	5.70	2.91	3.21	3.49	3.99	2.58
Total Operating Expenses	8.81	8.58	7.90	7.20	5.39	17	6.98	9.07	5.85	6.21	12
Selling, General & Admin Expense	3.46	2.42	1.59	1.59	0.24	1.77	2.22	1.74	1.96	2.28	2.57
Marketing Expense	4.09	4.85	5.01	4.40	4.16	4.38	3.84	3.79	3.17	3.09	3.27
Research & Development Expense	1.26	1.32	1.29	1.21	1.00	1.13	0.92	0.77	0.72	0.84	5.85
Total Other Income / (Expense), net	0.41	0.42	0.23	0.14	0.12	-0.05	0.00	0.00	-0.02	-0.30	-0.45
Other Income / (Expense), net	0.41	-	0.23	0.14	0.12	-0.05	-	0.00	-	-	-0.45
Income Tax Expense	0.00	-0.08	0.01	0.01	0.03	0.00	0.01	0.00	0.01	-0.07	0.01
Basic Earnings per Share	($0.88)	($7.93)	($0.73)	($0.50)	($0.35)	($21.09)	($5.53)	($0.58)	($0.20)	($4.61)	($6.70)
Weighted Average Basic Shares Outstanding	8.54M	710.94K	8.59M	8.61M	8.76M	724.27K	873.85K	11.23M	16.02M	1.16M	1.61M
Diluted Earnings per Share	($0.88)	($7.93)	($0.73)	($0.50)	($0.35)	($21.09)	($5.53)	($0.58)	($0.20)	($4.61)	($6.70)
Weighted Average Diluted Shares Outstanding	8.54M	710.94K	8.59M	8.61M	8.76M	724.27K	873.85K	11.23M	16.02M	1.16M	1.61M
Weighted Average Basic & Diluted Shares Outstanding	60.02M	59.48M	8.60M	8.77M	8.81M	10.63M	11.01M	15.70M	17.73M	1.53M	2.81M

This table details how cash moves in and out of Lifeward's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-24	6.60	-9.08	-5.08	6.65	4.06	68	-20	-40	-22	-4.53
Net Cash From Operating Activities	-25	-27	-22	-15	-15	-13	-11	-18	-21	-22	-17
Net Cash From Continuing Operating Activities	-25	-27	-22	-15	-15	-13	-11	-18	-21	-22	-17
Net Income / (Loss) Continuing Operations	-25	-33	-25	-22	-16	-13	-13	-20	-22	-29	-20
Consolidated Net Income / (Loss)	-25	-33	-25	-22	-16	-13	-13	-20	-22	-29	-20
Depreciation Expense	0.44	0.70	0.64	0.46	0.32	0.29	0.27	0.20	0.24	0.49	0.33
Amortization Expense	0.00	-	-	-	-	-	0.00	0.00	1.61	3.35	0.00
Non-Cash Adjustments To Reconcile Net Income	2.35	4.07	4.10	3.59	1.11	0.36	0.83	1.07	0.97	8.36	2.61
Changes in Operating Assets and Liabilities, net	-2.55	1.00	-2.48	2.85	-0.69	-0.26	0.17	0.40	-1.35	-4.97	0.14
Net Cash From Investing Activities	1.08	-0.44	-0.02	-0.01	-0.02	-0.07	-0.05	-0.03	-18	0.00	-0.02
Net Cash From Continuing Investing Activities	1.08	-0.44	-0.02	-0.01	-0.02	-0.07	-0.05	-0.03	-18	0.00	-0.02
Purchase of Property, Plant & Equipment	-0.58	-0.45	-0.02	-0.01	-0.02	-0.07	-0.05	-0.03	-0.08	0.00	-0.02
Acquisitions	-	-	-	-	-	-	0.00	0.00	-18	0.00	0.00
Net Cash From Financing Activities	0.14	34	13	9.71	21	17	80	-2.50	-0.99	0.00	12
Net Cash From Continuing Financing Activities	0.14	34	13	9.71	21	17	80	-2.50	-0.99	0.00	12
Issuance of Debt	0.00	20	-	0.00	0.00	0.39	-	-	0.00	0.00	1.44
Issuance of Common Equity	0.00	4.10	9.31	5.44	22	15	64	-	0.00	0.00	9.20
Other Financing Activities, net	0.14	11	7.20	8.14	1.43	8.23	15	-2.50	-0.99	0.00	1.56
Effect of Exchange Rate Changes	-	-	-	-	-	0.00	-	-	0.05	0.03	0.11
Cash Interest Received	-	-	-	-	-	-	0.00	0.00	1.34	0.65	0.08
Cash Income Taxes Paid	0.16	1.30	0.02	0.03	0.02	0.01	0.04	0.11	0.13	-0.01	0.04

This table details how cash moves in and out of Lifeward's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-26	-4.49	-7.69	-5.62	-4.47	-3.91	-1.02	-0.57	-3.16	0.22	9.25
Net Cash From Operating Activities	-7.44	-4.48	-7.67	-5.62	-4.46	-3.97	-5.49	-3.94	-3.84	-3.56	-3.68
Net Cash From Continuing Operating Activities	-7.44	-4.48	-7.67	-5.62	-4.46	-3.97	-5.49	-3.94	-3.84	-3.56	-3.68
Net Income / (Loss) Continuing Operations	-7.53	-5.64	-6.28	-4.30	-3.08	-15	-4.83	-6.56	-3.17	-5.35	-11
Consolidated Net Income / (Loss)	-7.53	-5.64	-6.28	-4.30	-3.08	-15	-4.83	-6.56	-3.17	-5.35	-11
Depreciation Expense	0.07	0.11	0.13	0.12	0.12	0.12	0.09	0.09	0.08	0.07	0.06
Amortization Expense	0.76	0.84	0.83	0.83	0.84	0.84	0.00	-	-	-	5.89
Non-Cash Adjustments To Reconcile Net Income	0.40	-0.04	0.38	-0.11	-1.70	9.78	0.30	2.29	0.14	-0.04	-0.19
Changes in Operating Assets and Liabilities, net	-1.14	0.24	-2.74	-2.16	-0.64	0.56	-1.05	0.24	-0.90	1.76	1.36
Net Cash From Investing Activities	-18	-0.08	0.00	-	-	-	-0.01	-	-	-0.01	6.50
Net Cash From Continuing Investing Activities	-18	-0.08	0.00	-	-	-	-0.01	-	-	-0.01	6.50
Purchase of Property, Plant & Equipment	-0.00	-0.08	0.00	-	-	-	-0.01	-	-	-0.01	0.00
Acquisitions	-	-	-	-	-	-	0.00	-	-	-	6.50
Net Cash From Financing Activities	-0.01	-	0.00	-	-	-	4.47	3.31	0.65	3.78	6.42
Net Cash From Continuing Financing Activities	-0.01	-	0.00	-	-	-	4.47	3.31	0.65	3.78	6.42
Issuance of Debt	-	-	-	-	-	-	0.00	-	-	-	4.60
Issuance of Common Equity	-	-	0.00	-	-	-	4.47	3.31	0.65	0.78	0.00
Other Financing Activities, net	-	-	-	-	-	-	0.00	-	-	-	1.82
Effect of Exchange Rate Changes	-0.03	0.07	-0.02	-	-	-	0.01	-	-	-	0.00

This table presents Lifeward's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	26	32	23	15	24	28	95	74	63	30	23
Total Current Assets	24	29	21	13	21	25	93	73	39	21	16
Cash & Equivalents	18	24	15	9.55	16	20	88	68	28	6.75	2.17
Restricted Cash	-	-	-	-	-	-	-	-	0.00	0.20	0.24
Accounts Receivable	2.15	1.25	1.10	0.76	0.79	0.68	0.59	1.04	3.12	6.00	6.14
Inventories, net	2.53	3.26	3.64	2.24	3.12	3.54	2.99	2.93	5.65	6.72	5.73
Prepaid Expenses	1.23	1.14	1.63	0.69	0.90	0.67	0.61	0.65	2.37	1.62	1.53
Plant, Property, & Equipment, net	1.33	1.26	0.84	0.63	0.50	0.44	0.28	0.20	1.26	0.87	0.59
Total Noncurrent Assets	0.47	1.17	1.09	1.10	2.80	2.38	1.95	1.53	23	8.33	6.51
Goodwill	-	-	-	-	-	-	-	0.00	7.54	7.54	4.76
Other Noncurrent Operating Assets	0.47	1.17	1.09	1.10	2.80	2.38	1.95	1.53	2.65	0.79	1.75
Total Liabilities & Shareholders' Equity	26	32	23	15	24	28	95	74	63	30	23
Total Liabilities	4.65	24	19	13	14	6.29	5.37	6.07	17	12	14
Total Current Liabilities	4.34	12	9.73	5.38	10	4.67	4.04	4.78	12	10	12
Short-Term Debt	0.00	7.50	6.44	1.72	5.44	0.00	-	-	-	0.00	2.80
Accounts Payable	2.47	3.42	1.81	2.33	2.70	2.27	1.38	1.95	5.07	5.02	5.59
Current Deferred Revenue	0.20	0.05	0.12	0.24	0.32	0.44	0.32	0.30	1.50	1.25	0.92
Current Employee Benefit Liabilities	1.22	1.02	0.87	0.65	0.67	0.87	1.14	1.28	2.03	1.33	1.44
Other Current Liabilities	0.45	0.41	0.48	0.45	1.04	1.09	1.20	1.25	3.19	2.62	1.28
Total Noncurrent Liabilities	0.31	11	9.43	7.64	3.42	1.63	1.33	1.29	4.89	1.41	2.45
Long-Term Debt	0.00	11	8.91	6.97	1.53	0.00	-	-	-	-	0.00
Noncurrent Deferred Revenue	0.17	0.28	0.26	0.43	0.52	0.67	0.87	0.89	1.51	1.32	1.23
Other Noncurrent Operating Liabilities	0.14	0.30	0.26	0.24	1.38	0.96	0.46	0.40	3.38	0.09	1.22
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	21	8.26	3.71	1.95	11	22	89	68	47	19	8.41
Total Preferred & Common Equity	21	8.26	3.71	1.95	11	22	89	68	47	19	8.41
Total Common Equity	21	8.26	3.71	1.95	11	22	89	68	47	19	8.41
Common Stock	95	115	135	155	179	203	284	284	286	287	296
Retained Earnings	-74	-106	-131	-153	-168	-181	-194	-214	-236	-265	-285
Treasury Stock	-	-	-	-	-	-	0.00	-2.43	-3.20	-3.20	-3.20

This table presents Lifeward's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	69	55	51	46	29	27	23	33
Total Current Assets	44	33	30	26	20	21	17	26
Cash & Equivalents	33	21	15	11	5.73	5.14	1.96	11
Restricted Cash	-	-	-	-	0.19	0.21	0.23	0.01
Accounts Receivable	3.53	3.49	5.27	5.84	5.17	5.86	6.13	5.66
Inventories, net	6.04	6.06	7.19	7.30	6.80	7.62	7.11	6.25
Prepaid Expenses	2.25	2.49	2.05	1.82	1.93	1.87	1.92	1.84
Other Current Assets	-	-	-	-	-	-	-	0.37
Plant, Property, & Equipment, net	1.05	1.21	1.26	1.22	0.78	0.73	0.64	0.57
Total Noncurrent Assets	24	21	20	19	8.21	5.34	5.18	7.29
Goodwill	7.54	7.54	7.54	7.54	7.54	4.76	4.76	4.76
Intangible Assets	13	12	11	10	0.00	0.00	0.00	0.00
Other Noncurrent Operating Assets	2.85	1.99	1.69	1.38	0.68	0.58	0.43	2.54
Total Liabilities & Shareholders' Equity	69	55	51	46	29	27	23	33
Total Liabilities	17	15	14	12	10	12	10	27
Total Current Liabilities	13	10	9.97	9.66	9.07	10	9.05	11
Short-Term Debt	-	-	-	-	-	-	-	0.00
Accounts Payable	5.66	4.28	4.85	4.99	4.47	6.11	5.25	6.38
Current Deferred Revenue	1.61	1.43	1.39	1.36	1.33	1.17	1.16	0.97
Current Employee Benefit Liabilities	1.70	1.49	1.56	1.48	1.17	1.17	1.25	1.29
Other Current Liabilities	3.84	2.90	2.17	1.83	2.10	1.91	1.39	2.01
Total Noncurrent Liabilities	4.63	4.51	4.33	2.22	1.28	1.31	1.36	16
Long-Term Debt	-	-	-	-	-	-	-	7.28
Noncurrent Deferred Revenue	1.65	1.36	1.31	1.30	1.17	1.18	1.21	1.21
Other Noncurrent Operating Liabilities	2.98	3.15	3.01	0.92	0.11	0.13	0.15	8.01
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	52	41	37	34	18	15	13	6.29
Total Preferred & Common Equity	52	41	37	34	18	15	13	6.29
Total Common Equity	52	41	37	34	18	15	13	6.29
Common Stock	285	286	286	287	291	295	295	305
Retained Earnings	-230	-242	-246	-250	-270	-276	-279	-296
Treasury Stock	-3.20	-3.20	-3.20	-3.20	-3.20	-3.20	-3.20	-3.20

This table displays calculated financial ratios and metrics derived from Lifeward's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	11,978,554.00	16,334,008.00	22,066,352.00	35,781,931.00	7,305,151.00	19,177,201.00	62,455,859.00	62,018,860.00	60,024,643.00	8,808,143.00	17,732,137.00
DEI Adjusted Shares Outstanding	1,711,222.00	2,333,430.00	3,152,336.00	5,111,704.00	1,043,593.00	2,739,600.00	8,922,266.00	8,859,837.00	714,579.00	734,012.00	1,477,678.00
DEI Earnings Per Adjusted Shares Outstanding	-14.85	-13.93	-7.84	-4.24	-14.90	-4.74	-1.43	-2.21	-30.97	-39.43	-13.48
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-5.19%	56.67%	32.10%	-15.58%	-25.55%	-9.85%	35.81%	-7.63%	151.39%	85.24%	-14.14%
EBITDA Growth	-14.99%	-28.57%	25.66%	10.26%	28.25%	23.02%	-5.72%	-52.55%	-7.40%	-23.45%	21.64%
EBIT Growth	-16.42%	-29.10%	25.28%	10.73%	28.30%	22.77%	-5.42%	-50.94%	-15.93%	-30.50%	30.90%
NOPAT Growth	-26.34%	-20.92%	27.76%	12.63%	26.89%	14.55%	-5.42%	-50.94%	-23.61%	-24.29%	32.96%
Net Income Growth	-17.29%	-27.89%	23.95%	12.31%	28.25%	16.56%	1.85%	-53.65%	-13.10%	-30.76%	31.19%
EPS Growth	66.88%	-17.62%	23.95%	12.31%	81.66%	69.63%	67.07%	-53.65%	-13.10%	-30.76%	31.19%
Operating Cash Flow Growth	-64.37%	-6.22%	16.02%	34.23%	-0.28%	15.03%	8.90%	-55.99%	-15.52%	-5.09%	22.53%
Free Cash Flow Firm Growth	2.36%	-11.82%	17.08%	41.91%	-1.95%	18.60%	-1.75%	-48.51%	-175.41%	59.58%	23.92%
Invested Capital Growth	50.74%	-14.95%	73.10%	-75.82%	37.38%	-4.56%	-26.54%	-74.28%	6,750.19%	-35.39%	-26.07%
Revenue Q/Q Growth	0.00%	4.54%	-0.97%	0.99%	-7.55%	0.85%	0.40%	20.49%	51.43%	2.64%	-10.06%
EBITDA Q/Q Growth	0.00%	-10.73%	9.37%	-4.10%	-5.28%	11.38%	-9.40%	-6.71%	9.00%	-52.50%	31.24%
EBIT Q/Q Growth	0.00%	-8.66%	9.37%	-3.94%	-4.93%	11.20%	-9.05%	-6.55%	1.49%	-42.67%	32.95%
NOPAT Q/Q Growth	0.00%	-1.77%	9.90%	7.89%	5.17%	3.43%	-9.05%	-6.55%	-5.04%	-44.88%	33.94%
Net Income Q/Q Growth	0.00%	-3.30%	8.79%	5.01%	8.49%	4.63%	-7.72%	-8.03%	-1.49%	-49.94%	33.27%
EPS Q/Q Growth	0.00%	0.00%	8.79%	5.01%	-15.88%	-13.89%	-8.00%	-8.03%	-1.49%	-49.94%	33.27%
Operating Cash Flow Q/Q Growth	0.00%	2.18%	4.78%	16.03%	-7.16%	8.25%	-0.95%	-8.14%	-2.84%	2.32%	2.40%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	5.93%	19.61%	-7.45%	14.45%	-9.90%	-2.01%	-3.98%	23.10%	-30.51%
Invested Capital Q/Q Growth	0.00%	-6.72%	10.15%	-44.90%	31.92%	-34.47%	-40.77%	-82.79%	-3.96%	-48.77%	-16.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	5.71%	12.54%	40.00%	43.16%	55.94%	49.83%	48.66%	34.57%	32.14%	32.02%	38.25%
EBITDA Margin	-660.33%	-541.90%	-304.95%	-324.17%	-312.39%	-266.77%	-207.66%	-342.95%	-146.51%	-97.64%	-89.12%
Operating Margin	-672.02%	-518.67%	-283.66%	-293.57%	-288.28%	-273.25%	-212.12%	-346.62%	-170.43%	-114.36%	-89.29%
EBIT Margin	-672.02%	-553.76%	-313.23%	-331.25%	-318.98%	-273.25%	-212.12%	-346.62%	-159.85%	-112.61%	-90.63%
Profit (Net Income) Margin	-678.46%	-553.81%	-318.81%	-331.17%	-319.13%	-295.38%	-213.48%	-355.09%	-159.76%	-112.78%	-90.38%
Tax Burden Percent	100.21%	100.01%	100.48%	99.98%	100.05%	100.39%	100.74%	102.44%	99.95%	100.15%	99.72%
Interest Burden Percent	100.75%	100.00%	101.29%	100.00%	100.00%	107.67%	99.90%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-694.46%	-754.82%	-434.44%	-482.24%	-762.89%	-576.32%	-717.29%	-2,033.67%	-176.81%	-135.45%	-133.01%
ROIC Less NNEP Spread (ROIC-NNEP)	-668.35%	-659.69%	-52.37%	21,748.03%	-650.19%	-545.46%	-710.15%	-2,025.74%	-165.13%	-87.49%	54.57%
Return on Net Nonoperating Assets (RNNOA)	615.98%	532.05%	21.35%	-284.74%	518.47%	496.60%	694.37%	2,008.83%	138.21%	46.89%	-13.11%
Return on Equity (ROE)	-78.47%	-222.78%	-413.09%	-766.99%	-244.42%	-79.72%	-22.92%	-24.84%	-38.60%	-88.56%	-146.12%
Cash Return on Invested Capital (CROIC)	-734.93%	-738.67%	-487.98%	-360.12%	-794.38%	-571.66%	-686.68%	-1,915.50%	-371.06%	-92.45%	-103.03%
Operating Return on Assets (OROA)	-68.74%	-113.36%	-88.91%	-114.63%	-79.04%	-45.78%	-20.61%	-22.61%	-32.23%	-61.70%	-74.81%
Return on Assets (ROA)	-69.40%	-113.38%	-90.50%	-114.61%	-79.07%	-49.49%	-20.74%	-23.16%	-32.21%	-61.79%	-74.60%
Return on Common Equity (ROCE)	-78.47%	-222.78%	-413.09%	-766.99%	-244.42%	-79.72%	-22.92%	-24.84%	-38.60%	-88.56%	-146.12%
Return on Equity Simple (ROE_SIMPLE)	-121.49%	-393.50%	-666.77%	-1,114.40%	-144.26%	-59.59%	-14.25%	-28.71%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-18	-21	-15	-13	-9.83	-8.40	-8.86	-13	-17	-21	-14
NOPAT Margin	-470.42%	-363.07%	-198.56%	-205.50%	-201.80%	-191.28%	-148.48%	-242.63%	-119.30%	-80.05%	-62.50%
Net Nonoperating Expense Percent (NNEP)	-26.11%	-95.13%	-382.07%	-22,230.27%	-112.69%	-30.86%	-7.14%	-7.93%	-11.68%	-47.96%	-187.58%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-19.62%	-35.54%	-108.99%	-122.84%
Cost of Revenue to Revenue	94.29%	87.46%	60.00%	56.84%	44.06%	50.17%	51.34%	65.43%	67.86%	67.99%	61.75%
SG&A Expenses to Revenue	170.72%	139.51%	99.20%	103.79%	107.92%	113.36%	94.30%	129.45%	72.15%	20.24%	37.19%
R&D to Revenue	158.49%	153.83%	77.93%	112.28%	109.75%	78.74%	49.26%	73.14%	29.94%	18.02%	14.75%
Operating Expenses to Revenue	677.74%	531.21%	323.66%	336.73%	344.22%	323.08%	260.78%	381.18%	202.58%	146.37%	127.54%
Earnings before Interest and Taxes (EBIT)	-25	-33	-24	-22	-16	-12	-13	-19	-22	-29	-20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-25	-32	-24	-21	-15	-12	-12	-19	-20	-25	-20
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	207.13	138.42	163.70	80.07	1.46	1.16	0.86	0.69	1.00	0.81	1.22
Price to Tangible Book Value (P/TBV)	207.13	138.42	163.70	80.07	1.46	1.16	0.86	0.69	1.77	1.35	2.80
Price to Revenue (P/Rev)	1,156.77	194.82	78.27	23.80	3.24	5.76	12.88	8.55	3.37	0.59	0.46
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1,414.41	438.43	135.26	142.62	4.35	3.49	0.00	0.00	1.01	0.70	1.21
Enterprise Value to Revenue (EV/Rev)	1,151.99	193.85	78.37	23.66	1.33	1.13	0.00	0.00	1.34	0.32	0.48
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	2.18	4.14	4.47	0.65	0.00	0.00	0.00	0.00	0.00	0.33
Long-Term Debt to Equity	0.00	1.27	2.40	3.58	0.14	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.92	-0.81	-0.41	-0.01	-0.80	-0.91	-0.98	-0.99	-0.84	-0.54	-0.24
Leverage Ratio	1.13	1.96	4.56	6.69	3.09	1.61	1.10	1.07	1.20	1.43	1.96
Compound Leverage Factor	1.14	1.96	4.62	6.69	3.09	1.73	1.10	1.07	1.20	1.43	1.96
Debt to Total Capital	0.00%	68.56%	80.55%	81.71%	39.25%	0.00%	0.00%	0.00%	0.00%	0.00%	25.00%
Short-Term Debt to Total Capital	0.00%	28.53%	33.80%	16.20%	30.65%	0.00%	0.00%	0.00%	0.00%	0.00%	25.00%
Long-Term Debt to Total Capital	0.00%	40.03%	46.75%	65.51%	8.61%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	31.44%	19.45%	18.29%	60.75%	100.00%	100.00%	100.00%	100.00%	100.00%	75.00%
Debt to EBITDA	0.00	-0.57	-0.65	-0.41	-0.46	0.00	0.00	0.00	0.00	0.00	-0.14
Net Debt to EBITDA	0.00	0.18	-0.03	0.04	0.61	0.00	0.00	0.00	0.00	0.00	-0.02
Long-Term Debt to EBITDA	0.00	-0.33	-0.38	-0.33	-0.10	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	-0.85	-1.00	-0.65	-0.71	0.00	0.00	0.00	0.00	0.00	-0.20
Net Debt to NOPAT	0.00	0.27	-0.05	0.06	0.94	0.00	0.00	0.00	0.00	0.00	-0.03
Long-Term Debt to NOPAT	0.00	-0.49	-0.58	-0.52	-0.16	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	552.41	21.94	8.39	-10.84	-10.35	-7.01	6.46	0.95	-3.96	-13.23	-18.70
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.47	2.37	2.15	2.46	2.07	5.41	22.91	15.16	3.33	2.08	1.31
Quick Ratio	4.61	2.01	1.61	1.91	1.68	4.51	22.02	14.41	2.65	1.25	0.69
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-19	-21	-17	-10	-10	-8.33	-8.48	-13	-35	-14	-11
Operating Cash Flow to CapEx	-4,311.64%	-6,120.60%	-106,961.90%	-113,646.15%	-67,340.91%	-17,245.21%	-24,402.13%	-71,564.00%	-25,514.81%	0.00%	-105,162.50%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-55.24	0.00	0.00	-9.05	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	-71.76	0.00	0.00	-13.67	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	-71.83	0.00	0.00	-13.75	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.10	0.20	0.28	0.35	0.25	0.17	0.10	0.07	0.20	0.55	0.83
Accounts Receivable Turnover	1.83	3.45	6.58	7.03	6.28	5.94	9.40	6.80	6.67	5.63	3.63
Inventory Turnover	2.13	1.77	1.35	1.26	0.80	0.66	0.94	1.22	2.19	2.82	2.18
Fixed Asset Turnover	4.30	4.54	7.39	8.93	8.65	9.37	16.55	22.96	19.00	24.11	30.35
Accounts Payable Turnover	1.83	1.74	1.78	1.80	0.85	0.89	1.68	2.16	2.68	3.46	2.56
Days Sales Outstanding (DSO)	199.80	105.73	55.48	51.89	58.12	61.40	38.82	53.68	54.75	64.88	100.57
Days Inventory Outstanding (DIO)	171.08	206.14	270.96	288.61	455.87	551.89	389.13	299.51	166.60	129.46	167.06
Days Payable Outstanding (DPO)	199.65	209.70	205.37	203.06	427.22	411.20	217.59	168.73	136.26	105.55	142.34
Cash Conversion Cycle (CCC)	171.22	102.17	121.08	137.45	86.77	202.09	210.36	184.46	85.09	88.79	125.29
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3.05	2.60	4.49	1.09	1.49	1.42	1.05	0.27	18	12	8.80
Invested Capital Turnover	1.48	2.08	2.19	2.35	3.78	3.01	4.83	8.38	1.48	1.69	2.13
Increase / (Decrease) in Invested Capital	1.03	-0.46	1.90	-3.41	0.41	-0.07	-0.38	-0.78	18	-6.52	-3.10
Enterprise Value (EV)	4,315	1,138	608	155	6.49	4.96	-12	-21	19	8.30	11
Market Capitalization	4,333	1,143	607	156	16	25	77	47	47	15	10
Book Value per Share	$1.75	$0.51	$0.17	$0.05	$1.48	$1.14	$1.43	$1.10	$0.77	$2.14	$0.47
Tangible Book Value per Share	$1.75	$0.51	$0.17	$0.05	$1.48	$1.14	$1.43	$1.10	$0.44	$1.28	$0.21
Total Capital	21	26	19	11	18	22	89	68	47	19	11
Total Debt	0.00	18	15	8.69	6.97	0.00	0.00	0.00	0.00	0.00	2.80
Total Long-Term Debt	0.00	11	8.91	6.97	1.53	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-18	-5.67	0.79	-0.86	-9.29	-20	-88	-68	-28	-6.94	0.39
Capital Expenditures (CapEx)	0.58	0.44	0.02	0.01	0.02	0.07	0.05	0.03	0.08	0.00	0.02
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1.56	0.75	3.09	0.03	0.09	0.23	0.15	-0.17	-0.66	4.13	4.16
Debt-free Net Working Capital (DFNWC)	19	24	18	9.58	16	21	88	68	27	11	6.57
Net Working Capital (NWC)	19	17	11	7.86	11	21	88	68	27	11	3.77
Net Nonoperating Expense (NNE)	7.79	11	9.32	8.23	5.72	4.57	3.88	6.20	5.60	8.40	6.14
Net Nonoperating Obligations (NNO)	-18	-5.67	0.79	-0.86	-9.29	-20	-88	-68	-28	-6.94	0.39
Total Depreciation and Amortization (D&A)	0.44	0.70	0.64	0.46	0.32	0.29	0.27	0.20	1.85	3.84	0.33
Debt-free, Cash-free Net Working Capital to Revenue	41.75%	12.85%	39.79%	0.47%	1.85%	5.24%	2.45%	-3.05%	-4.74%	16.08%	18.89%
Debt-free Net Working Capital to Revenue	518.77%	416.29%	227.68%	146.33%	335.38%	468.47%	1,483.12%	1,228.96%	197.97%	43.13%	29.82%
Net Working Capital to Revenue	518.77%	288.58%	144.60%	120.02%	223.78%	468.47%	1,483.12%	1,228.96%	197.97%	43.13%	17.10%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($2.10)	($2.47)	($1.22)	($0.59)	($2.70)	($0.82)	($0.27)	($2.17)	($31.08)	($39.96)	($17.16)
Adjusted Weighted Average Basic Shares Outstanding	12.34M	16.35M	30.01M	73.09M	12.75M	33.45M	62.51M	8.91M	710.94K	724.27K	1.16M
Adjusted Diluted Earnings per Share	($2.10)	($2.47)	($1.22)	($0.59)	($2.70)	($0.82)	($0.27)	($2.17)	($31.08)	($39.96)	($17.16)
Adjusted Weighted Average Diluted Shares Outstanding	12.34M	16.35M	30.01M	73.09M	12.75M	33.45M	62.51M	8.91M	710.94K	724.27K	1.16M
Adjusted Basic & Diluted Earnings per Share	($2.10)	($2.47)	($1.22)	($0.59)	($2.70)	($0.82)	($0.27)	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	12.12M	13.18M	20.21M	36.81M	5.76M	15.76M	47.94M	8.50M	708.10K	885.86K	1.53M
Normalized Net Operating Profit after Tax (NOPAT)	-18	-21	-15	-13	-9.83	-8.40	-8.86	-13	-17	-14	-12
Normalized NOPAT Margin	-470.42%	-363.07%	-198.56%	-205.50%	-201.80%	-191.28%	-148.48%	-242.63%	-119.30%	-53.33%	-53.66%
Pre Tax Income Margin	-677.04%	-553.76%	-317.27%	-331.25%	-318.98%	-294.22%	-211.90%	-346.62%	-159.85%	-112.61%	-90.63%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	-77.59	0.00	0.00	-13.03	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	-49.18	0.00	0.00	-9.12	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	-77.66	0.00	0.00	-13.11	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	-49.25	0.00	0.00	-9.20	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Lifeward's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	59,937,017.00	60,024,643.00	60,024,643.00	8,602,626.00	8,773,780.00	8,808,143.00	10,630,281.00	11,007,592.00	15,704,622.00	17,732,137.00	1,528,222.00
DEI Adjusted Shares Outstanding	8,562,431.00	714,579.00	8,574,949.00	8,602,626.00	8,773,780.00	734,012.00	885,857.00	11,007,592.00	15,704,622.00	1,477,678.00	1,528,222.00
DEI Earnings Per Adjusted Shares Outstanding	-0.88	-7.89	-0.73	-0.50	-0.35	-20.81	-5.46	-0.60	-0.20	-3.62	-7.06
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	396.95%	215.92%	329.51%	401.65%	39.18%	9.60%	-4.71%	-14.66%	1.09%	-32.66%	-22.07%
EBITDA Growth	-24.49%	-4.51%	-22.47%	26.77%	68.82%	-175.81%	10.37%	-93.48%	-46.34%	64.74%	-1.64%
EBIT Growth	-38.62%	-22.62%	-43.31%	6.54%	59.43%	-148.90%	22.60%	-52.64%	-2.78%	66.49%	-122.27%
NOPAT Growth	-46.18%	-22.62%	-48.62%	13.86%	60.04%	-148.13%	25.36%	-47.72%	1.07%	66.39%	-113.04%
Net Income Growth	-37.93%	-6.14%	-45.24%	7.28%	59.05%	-170.93%	22.98%	-52.46%	-2.79%	65.00%	-123.27%
EPS Growth	-37.93%	-6.14%	-43.14%	9.09%	60.23%	-170.93%	22.98%	-16.00%	42.86%	65.00%	-21.16%
Operating Cash Flow Growth	-61.79%	-14.59%	-46.63%	-60.21%	40.10%	11.49%	28.41%	29.93%	13.84%	10.43%	33.10%
Free Cash Flow Firm Growth	-543.94%	-723.54%	-962.55%	-929.32%	72.93%	81.57%	117.29%	130.18%	266.94%	88.44%	-19.75%
Invested Capital Growth	1,127.51%	6,750.19%	1,114.61%	2,628.61%	21.13%	-35.39%	-36.92%	-54.74%	-54.54%	-26.07%	-82.97%
Revenue Q/Q Growth	229.32%	56.35%	-23.26%	26.95%	-8.63%	23.12%	-33.28%	13.71%	8.23%	-17.98%	-22.79%
EBITDA Q/Q Growth	-46.64%	22.57%	-2.43%	37.03%	37.57%	-584.97%	66.71%	-36.78%	52.78%	-65.06%	4.06%
EBIT Q/Q Growth	-63.72%	18.51%	-2.17%	31.44%	28.94%	-400.00%	68.23%	-36.06%	52.15%	-62.99%	-110.77%
NOPAT Q/Q Growth	-53.97%	22.73%	-5.95%	31.67%	28.56%	-379.77%	68.13%	-35.24%	52.16%	-62.99%	-102.01%
Net Income Q/Q Growth	-62.24%	25.12%	-11.30%	31.42%	28.35%	-395.40%	68.36%	-35.75%	51.69%	-68.71%	-101.81%
EPS Q/Q Growth	-62.24%	25.12%	-10.61%	31.51%	30.00%	-395.40%	68.36%	-26.09%	65.52%	-68.71%	-45.34%
Operating Cash Flow Q/Q Growth	-112.32%	39.76%	-71.12%	26.80%	20.62%	10.99%	-38.40%	28.35%	2.39%	7.47%	-3.38%
Free Cash Flow Firm Q/Q Growth	-899.41%	3.14%	-1.48%	-4.78%	73.72%	34.05%	195.20%	82.87%	45.41%	-104.57%	760.61%
Invested Capital Q/Q Growth	2,328.61%	-3.96%	7.84%	8.48%	7.81%	-48.77%	5.27%	-22.16%	8.28%	-16.69%	-75.74%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	19.60%	35.49%	26.41%	41.11%	36.23%	24.44%	42.15%	43.87%	43.70%	21.41%	34.21%
EBITDA Margin	-152.17%	-75.36%	-100.59%	-49.89%	-34.09%	-189.65%	-94.62%	-113.10%	-49.35%	-99.31%	-123.40%
Operating Margin	-180.38%	-89.15%	-123.07%	-66.24%	-51.80%	-201.83%	-96.40%	-114.66%	-50.69%	-100.73%	-263.55%
EBIT Margin	-171.04%	-89.15%	-118.68%	-64.10%	-49.85%	-202.45%	-96.40%	-114.64%	-50.69%	-100.73%	-274.97%
Profit (Net Income) Margin	-171.04%	-81.91%	-118.80%	-64.17%	-50.33%	-202.49%	-96.03%	-114.64%	-51.17%	-105.25%	-275.12%
Tax Burden Percent	100.00%	98.64%	100.10%	100.12%	100.95%	100.02%	100.23%	100.00%	100.22%	98.65%	100.06%
Interest Burden Percent	100.00%	93.16%	100.00%	100.00%	100.00%	100.00%	99.38%	100.00%	100.73%	105.92%	100.00%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-111.35%	-92.48%	-143.46%	-96.61%	-42.73%	-239.06%	-105.85%	-125.24%	-51.42%	-150.05%	-526.27%
ROIC Less NNEP Spread (ROIC-NNEP)	-107.65%	-89.69%	-139.29%	-93.35%	-38.74%	-212.69%	-95.07%	-106.03%	-36.29%	-96.14%	-455.71%
Return on Net Nonoperating Assets (RNNOA)	90.11%	75.06%	110.52%	71.54%	19.56%	113.98%	42.92%	41.93%	9.99%	23.10%	185.58%
Return on Equity (ROE)	-21.24%	-17.42%	-32.94%	-25.06%	-23.18%	-125.08%	-62.93%	-83.31%	-41.43%	-126.95%	-340.69%
Cash Return on Invested Capital (CROIC)	-321.55%	-371.06%	-337.12%	-342.64%	-85.95%	-92.45%	-74.38%	-57.95%	-48.36%	-103.03%	-98.34%
Operating Return on Assets (OROA)	-20.87%	-17.97%	-34.22%	-25.55%	-21.68%	-110.92%	-58.32%	-72.04%	-36.02%	-83.15%	-184.91%
Return on Assets (ROA)	-20.87%	-16.52%	-34.26%	-25.58%	-21.88%	-110.94%	-58.09%	-72.04%	-36.37%	-86.88%	-185.01%
Return on Common Equity (ROCE)	-21.24%	-17.42%	-32.94%	-25.06%	-23.18%	-125.08%	-62.93%	-83.31%	-41.43%	-126.95%	-340.69%
Return on Equity Simple (ROE_SIMPLE)	-42.12%	0.00%	-59.31%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	-5.56	-4.30	-4.55	-3.11	-2.22	-11	-3.40	-4.59	-2.20	-3.58	-7.24
NOPAT Margin	-126.26%	-62.40%	-86.15%	-46.37%	-36.26%	-141.28%	-67.48%	-80.26%	-35.48%	-70.51%	-184.48%
Net Nonoperating Expense Percent (NNEP)	-3.70%	-2.80%	-4.17%	-3.26%	-3.99%	-26.37%	-10.78%	-19.21%	-15.14%	-53.91%	-70.56%
Return On Investment Capital (ROIC_SIMPLE)	-	-9.24%	-11.21%	-8.48%	-6.56%	-56.55%	-18.41%	-30.40%	-17.23%	-31.96%	-53.34%
Cost of Revenue to Revenue	80.40%	64.51%	73.59%	58.89%	63.77%	75.56%	57.85%	56.13%	56.30%	78.59%	65.79%
SG&A Expenses to Revenue	78.47%	35.10%	30.13%	23.74%	3.92%	23.47%	44.10%	30.38%	31.61%	44.83%	65.38%
R&D to Revenue	28.66%	19.15%	24.44%	17.97%	16.29%	14.99%	18.24%	13.40%	11.64%	16.59%	148.99%
Operating Expenses to Revenue	199.98%	124.64%	149.48%	107.35%	88.02%	226.27%	138.56%	158.53%	94.38%	122.14%	297.76%
Earnings before Interest and Taxes (EBIT)	-7.53	-6.14	-6.27	-4.30	-3.06	-15	-4.85	-6.56	-3.14	-5.12	-11
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-6.70	-5.19	-5.31	-3.35	-2.09	-14	-4.76	-6.47	-3.06	-5.05	-4.84
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.88	1.00	1.10	0.94	0.84	0.81	0.98	0.47	0.88	1.22	1.61
Price to Tangible Book Value (P/TBV)	1.48	1.77	2.10	1.89	1.75	1.35	1.66	0.69	1.40	2.80	6.60
Price to Revenue (P/Rev)	4.98	3.37	2.50	1.48	1.14	0.59	0.71	0.29	0.46	0.46	0.48
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.68	1.01	1.21	0.90	0.77	0.70	0.97	0.18	0.85	1.21	2.80
Enterprise Value to Revenue (EV/Rev)	1.42	1.34	1.35	0.83	0.72	0.32	0.48	0.07	0.37	0.48	0.29
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.33	1.16
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.16
Financial Leverage	-0.84	-0.84	-0.79	-0.77	-0.50	-0.54	-0.45	-0.40	-0.28	-0.24	-0.41
Leverage Ratio	1.18	1.20	1.19	1.22	1.34	1.43	1.42	1.50	1.48	1.96	2.51
Compound Leverage Factor	1.18	1.12	1.19	1.22	1.34	1.43	1.41	1.50	1.49	2.07	2.51
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	25.00%	53.63%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	25.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	53.63%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	75.00%	46.37%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.14	-0.38
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	0.22
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.38
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.20	-0.41
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.03	0.24
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.41
Altman Z-Score	-2.77	-3.13	-3.85	-4.68	-5.44	-11.75	-11.28	-13.51	-15.20	-16.56	-12.06
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.47	3.33	3.25	2.97	2.65	2.08	2.18	2.00	1.92	1.31	2.40
Quick Ratio	2.82	2.65	2.40	2.05	1.71	1.25	1.20	1.06	0.89	0.69	1.61
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-23	-22	-23	-24	-6.28	-4.14	3.94	7.20	10	-0.48	3.16
Operating Cash Flow to CapEx	-372,200.00%	-5,675.95%	0.00%	0.00%	0.00%	0.00%	-109,860.00%	0.00%	0.00%	-32,318.18%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.12	0.20	0.29	0.40	0.43	0.55	0.60	0.63	0.71	0.83	0.67
Accounts Receivable Turnover	4.60	6.67	8.90	7.70	5.34	5.63	5.87	4.39	4.09	3.63	3.86
Inventory Turnover	1.38	2.19	2.78	3.09	2.43	2.82	2.56	2.12	2.13	2.18	2.03
Fixed Asset Turnover	14.25	19.00	26.22	33.59	22.09	24.11	25.63	24.59	26.37	30.35	31.04
Accounts Payable Turnover	1.71	2.68	4.17	4.11	3.04	3.46	3.77	2.87	2.99	2.56	2.45
Days Sales Outstanding (DSO)	79.31	54.75	41.00	47.38	68.41	64.88	62.16	83.16	89.16	100.57	94.46
Days Inventory Outstanding (DIO)	264.55	166.60	131.29	118.03	150.44	129.46	142.50	171.84	171.74	167.06	179.45
Days Payable Outstanding (DPO)	213.55	136.26	87.55	88.78	120.07	105.55	96.88	127.15	122.07	142.34	149.05
Cash Conversion Cycle (CCC)	130.31	85.09	84.74	76.64	98.77	88.79	107.78	127.86	138.84	125.29	124.85
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	19	18	20	22	23	12	13	9.76	11	8.80	2.14
Invested Capital Turnover	0.88	1.48	1.67	2.08	1.18	1.69	1.57	1.56	1.45	2.13	2.85
Increase / (Decrease) in Invested Capital	18	18	18	21	4.05	-6.52	-7.34	-12	-13	-3.10	-10
Enterprise Value (EV)	13	19	24	19	18	8.30	12	1.74	8.99	11	5.98
Market Capitalization	46	47	45	34	29	15	18	7.10	11	10	10
Book Value per Share	$0.86	$0.77	$4.73	$4.26	$3.86	$2.14	$1.74	$1.37	$0.81	$0.47	$4.12
Tangible Book Value per Share	$0.52	$0.44	$2.49	$2.13	$1.86	$1.28	$1.03	$0.94	$0.51	$0.21	$1.01
Total Capital	52	47	41	37	34	19	18	15	13	11	14
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.80	7.28
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	7.28
Net Debt	-33	-28	-21	-15	-11	-6.94	-5.92	-5.35	-2.19	0.39	-4.16
Capital Expenditures (CapEx)	0.00	0.08	0.00	0.00	0.00	0.00	0.01	0.00	0.00	0.01	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-0.99	-0.66	1.95	4.54	5.30	4.13	4.83	5.00	6.10	4.16	3.49
Debt-free Net Working Capital (DFNWC)	32	27	23	20	16	11	11	10	8.29	6.57	15
Net Working Capital (NWC)	32	27	23	20	16	11	11	10	8.29	3.77	15
Net Nonoperating Expense (NNE)	1.97	1.34	1.72	1.19	0.86	4.62	1.44	1.97	0.97	1.77	3.56
Net Nonoperating Obligations (NNO)	-33	-28	-21	-15	-11	-6.94	-5.92	-5.35	-2.19	0.39	-4.16
Total Depreciation and Amortization (D&A)	0.83	0.95	0.96	0.95	0.97	0.97	0.09	0.09	0.08	0.07	5.95
Debt-free, Cash-free Net Working Capital to Revenue	-10.80%	-4.74%	10.89%	19.50%	21.21%	16.08%	18.99%	20.45%	24.91%	18.89%	16.68%
Debt-free Net Working Capital to Revenue	345.41%	197.97%	126.73%	84.50%	63.82%	43.13%	42.29%	42.36%	33.85%	29.82%	71.32%
Net Working Capital to Revenue	345.41%	197.97%	126.73%	84.50%	63.82%	43.13%	42.29%	42.36%	33.85%	17.10%	71.32%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.91)	($666.12)	($0.73)	($0.50)	($0.35)	($253.08)	($5.52)	($0.58)	($0.20)	($55.32)	($6.70)
Adjusted Weighted Average Basic Shares Outstanding	8.54M	8.46K	8.59M	8.61M	8.76M	60.36K	873.85K	11.23M	16.02M	96.71K	1.61M
Adjusted Diluted Earnings per Share	($0.91)	($666.12)	($0.73)	($0.50)	($0.35)	($253.08)	($5.52)	($0.58)	($0.20)	($55.32)	($6.70)
Adjusted Weighted Average Diluted Shares Outstanding	8.54M	8.46K	8.59M	8.61M	8.76M	60.36K	873.85K	11.23M	16.02M	96.71K	1.61M
Adjusted Basic & Diluted Earnings per Share	$0.00	($666.12)	$0.00	$0.00	$0.00	($253.08)	$0.00	$0.00	$0.00	($55.32)	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	8.57M	708.10K	8.60M	8.77M	8.81M	885.86K	917.30K	15.70M	17.73M	127.35K	2.81M
Normalized Net Operating Profit after Tax (NOPAT)	-5.56	-4.30	-4.55	-3.11	-2.22	-11	-3.40	-2.65	-2.20	-3.58	-7.24
Normalized NOPAT Margin	-126.26%	-62.40%	-86.15%	-46.37%	-36.26%	-141.28%	-67.48%	-46.23%	-35.48%	-70.51%	-184.48%
Pre Tax Income Margin	-171.04%	-83.05%	-118.68%	-64.10%	-49.85%	-202.45%	-95.81%	-114.64%	-51.06%	-106.69%	-274.97%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Lifeward (NASDAQ: LFWD) remains a highly cash-burned, unprofitable company, but the latest quarter shows a meaningful improvement in liquidity after a large financing and acquisition-related cash inflow. Revenue in Q1 2026 was $3.9 million, down from $5.1 million in Q4 2025 and $6.2 million in Q3 2025, while the company still posted a sizable net loss of $10.8 million. Even so, cash and equivalents rose to $11.4 million from $2.0 million in the prior quarter, largely due to financing activity and a reported acquisition-related cash inflow.

What stands out most is the balance sheet reset. Total assets were $33.4 million at the end of Q1 2026, versus $23.2 million in Q3 2025, while total liabilities also increased to $27.1 million from $10.4 million. Equity was reduced to $6.3 million from $12.8 million, reflecting continued losses and a more leveraged capital structure. Lifeward is still operating with negative retained earnings of $295.5 million, underscoring its long history of cumulative losses.

Here are the key takeaways for investors:

Cash and equivalents improved sharply to $11.4 million in Q1 2026 from $2.0 million in Q3 2025, giving Lifeward more near-term liquidity.
The company generated positive financing cash flow of $6.4 million in Q1 2026, helped by $4.6 million of debt issuance and $1.8 million in other financing activity.
Revenue in Q1 2026 rebounded sequentially from Q4 2025 to $3.9 million after a weak prior quarter.
Gross profit in Q1 2026 was $1.3 million, showing the business still clears a positive gross margin before operating expenses.
Short-term debt remained at $0.0 in Q1 2026, which reduces immediate refinancing pressure at the current liability level.
The company reported no material capital spending in Q1 2026, suggesting limited near-term cash use for fixed assets.
A large acquisition-related investing cash inflow was reported in Q1 2026, but this is unusual and may not repeat.
Q1 2026 net loss widened to $10.8 million, compared with a $5.3 million loss in Q4 2025 and $3.2 million in Q3 2025.
Operating loss in Q1 2026 was $10.3 million, indicating the core business remains far from break-even.
Operating cash flow was negative $3.7 million in Q1 2026, so the business is still burning cash from operations.

Longer-term trend: Lifeward has shown a recurring pattern of quarterly losses and negative operating cash flow over the past year. Revenue has fluctuated between roughly $3.9 million and $7.5 million, but expenses have generally outpaced sales. There was also a major change in share count over time, with weighted average shares rising materially versus earlier periods, which points to dilution risk for existing shareholders.

Bottom line: Lifeward’s latest quarter is better viewed as a liquidity improvement than a business turnaround. The stronger cash position buys time, but the company still needs to demonstrate sustained revenue growth, lower operating losses, and positive operating cash flow before investors can argue that the fundamental trend has truly changed.

07/21/26 12:24 AM ETAI Generated. May Contain Errors.

Lifeward Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Lifeward's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Lifeward's net income appears to be on a downward trend, with a most recent value of -$19.91 million in 2025, falling from -$25.42 million in 2015. The previous period was -$28.94 million in 2024. Check out Lifeward's forecast to explore projected trends and price targets.

Lifeward's total operating income in 2025 was -$19.67 million, based on the following breakdown:

Total Gross Profit: $8.43 million
Total Operating Expenses: $28.10 million

Over the last 10 years, Lifeward's total revenue changed from $3.75 million in 2015 to $22.03 million in 2025, a change of 488.2%.

Lifeward's total liabilities were at $14.49 million at the end of 2025, a 24.5% increase from 2024, and a 211.4% increase since 2015.

In the past 10 years, Lifeward's cash and equivalents has ranged from $2.17 million in 2025 to $88.34 million in 2021, and is currently $2.17 million as of their latest financial filing in 2025.

Over the last 10 years, Lifeward's book value per share changed from 1.75 in 2015 to 0.47 in 2025, a change of -72.8%.

Related Companies

Financial statements for NASDAQ:LFWD last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lifeward (LFWD) Financials

Financials Breakdown Chart

Key Financial Trends

Lifeward Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lifeward (LFWD) Financials

Annual Income Statements for Lifeward

Quarterly Income Statements for Lifeward

Annual Cash Flow Statements for Lifeward

Quarterly Cash Flow Statements for Lifeward

Annual Balance Sheets for Lifeward

Quarterly Balance Sheets for Lifeward

Annual Metrics And Ratios for Lifeward

Quarterly Metrics And Ratios for Lifeward

Financials Breakdown Chart

Key Financial Trends

Lifeward Financials - Frequently Asked Questions

When does Lifeward's financial year end?

How has Lifeward's net income changed over the last 10 years?

What is Lifeward's operating income?

How has Lifeward's revenue changed over the last 10 years?

How much debt does Lifeward have?

How much cash does Lifeward have?

How has Lifeward's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools